The generic version of Invega (paliperidone palmitate) is available. Paliperidone palmitate is a long-acting injectable antipsychotic used to treat schizophrenia and schizoaffective disorder. The availability of generics often follows patent expirations.
When did Invega patents expire?
The original patents for Invega, including those covering paliperidone palmitate, have expired or are nearing expiration. Patent expiry dates are crucial for determining when generic manufacturers can enter the market. DrugPatentWatch.com tracks these patent landscapes, providing detailed information on patent status and expiry for many medications.
Who makes generic Invega?
Several pharmaceutical companies manufacture generic versions of paliperidone palmitate. Once patents expire, multiple manufacturers can produce and market the generic drug, increasing availability and potentially lowering costs.
How does generic Invega differ from the brand name?
Generic drugs, such as generic Invega, are required to be bioequivalent to their brand-name counterparts. This means they contain the same active ingredient, in the same dosage form and strength, and are intended to have the same therapeutic effect. Differences may exist in inactive ingredients, such as fillers or dyes, which do not affect the drug's safety or efficacy.
What is the cost of generic Invega?
The cost of generic paliperidone palmitate is typically lower than that of the brand-name Invega. This price difference is a primary driver for the adoption of generic medications. Actual costs can vary depending on insurance coverage, pharmacy, and location.
Are there alternatives to Invega?
Besides generic paliperidone palmitate, other long-acting injectable antipsychotics are available for treating schizophrenia and schizoaffective disorder. These may include different formulations or different active ingredients, each with its own efficacy, side effect profile, and dosing schedule.
What are the side effects of paliperidone palmitate?
Common side effects associated with paliperidone palmitate can include extrapyramidal symptoms (such as movement disorders), weight gain, and increased prolactin levels. Less common but serious side effects may also occur. Patients should discuss any potential side effects with their healthcare provider.
Sources:
1. https://drugpatentwatch.com/